Clinical Trial Update: A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL) [Phase 1]

View source ↗

Summary

A Phase 1 study of 19-28z/IL-18 in adults with acute lymphoblastic leukemia is ongoing, including Philadelphia-negative and Philadelphia-positive subtypes, as w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Philadelphia-negative Acute Lymphoblastic Leukemia
• Philadelphia-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• 19-28z/IL-18

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Philadelphia-Negative ALL, Philadelphia-Positive ALL | Phase 1 | Status: RECRUITING